|
Report Date : |
22.05.2012 |
IDENTIFICATION DETAILS
|
Name : |
ATIVA
PHARMACEUTICALS CO., LTD. |
|
|
|
|
Registered Office : |
549/360 Soi Jaransanitwong 37, Jaransanitwong Road, Bangkhunsri, Bangkoknoi, Bangkok 10700 |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
19.01.2012 |
|
|
|
|
Com. Reg. No.: |
0105555008308 |
|
|
|
|
Legal Form : |
Private
Limited Company |
|
|
|
|
Line of Business : |
Importer and distributor
of Pharmaceutical products |
|
|
|
|
No. of Employees : |
08 |
RATING & COMMENTS
|
MIRA’s Rating : |
NB |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
---- |
NB |
New Business |
---- |
|
Status : |
New company |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
|
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
ATIVA PHARMACEUTICALS CO., LTD.
BUSINESS
ADDRESS : 252/25 JARANSANITWONG ROAD, BANCHANGLOR,
BANGKOKNOI, BANGKOK
10700, THAILAND
TELEPHONE : [66] 2411-6114-7,
081 617-6184
FAX :
[66] 2411-6118
E-MAIL
ADDRESS : saridphong@yahoo.com
REGISTRATION
ADDRESS : 549/360 SOI
JARANSANITWONG 37,
JARANSANITWONG ROAD,
BANGKHUNSRI,
BANGKOKNOI, BANGKOK
10700, THAILAND
ESTABLISHED
: 2012
REGISTRATION
NO. : 0105555008308
TAX
ID NO. : 3034853154
CAPITAL REGISTERED : BHT. 3,000,000
CAPITAL PAID-UP : BHT.
3,000,000
SHAREHOLDER’S PROPORTION : THAI : 51%
INDIAN : 49%
FISCAL YEAR CLOSING DATE : -
LEGAL
STATUS : PRIVATE LIMITED
COMPANY
EXECUTIVE : MR. SARIDPHONG MEKWORAWUTH,
THAI
MANAGING DIRECTOR
NO.
OF STAFF : 8
LINES
OF BUSINESS : PHARMACEUTICAL PRODUCTS
IMPORTER AND
DISTRIBUTOR
OPERATING
TREND : EARLY
STAGE
PRESENT
SITUATION : -
REPUTATION : -
MANAGEMENT
STANDARD : -
The
subject was established
on January 19,
2012 as a
private limited company under
the registered name
ATIVA PHARMACEUTICALS CO.,
LTD., by Thai and
Indian groups, with
the business objective
to distribute wide range
of human pharmaceutical products
to domestic market.
It currently employs
8 staff.
The subject’s registered address is 549/360 Soi Jaransanitwong 37, Jaransanitwong Rd., Bangkhunsri, Bangkoknoi, Bangkok 10700, while the subject’s current operation address is at 252/25 Jaransanitwong Rd., Banchanglor, Bangkoknoi, Bangkok 10700.
|
Name |
|
Nationality |
Age |
|
|
|
|
|
|
Mr. Prawit Plaimas |
|
Thai |
32 |
|
Mr. Saridphong Mekworawuth |
|
Thai |
36 |
|
Mr. Nirav Vikram Maniar |
|
Indian |
36 |
Any two of
the above directors
can jointly sign
on behalf of
the subject with
company’s affixed.
Mr. Saridphong Mekworawuth is
the Managing Director.
He is Thai
nationality with the
age of 36
years old.
The subject is engaged
in importing and
distributing wide range of
human pharmaceutical products
including Antibiotics, Antihypertensive, Antianginals,
Anticoagulants, Neuromuscular
Disorder drug, Anti-ulcerants, Nootropic,
Neurotonic and etc.
PURCHASE
Most of the
products are imported
from India, the
remaining is purchased
from local suppliers
and agents.
MAJOR
SUPPLIERS
Cadila
Healthcare Pvt. Ltd. : India
F D C
Limited : India
Kaspa
Pharmaceutical [Thailand] Co.,
Ltd. : Thailand
SALES
100% of the
products is sold
locally to wholesalers
and end-users, mainly
hospital both private
and government.
SUBSIDIARY AND AFFILIATED
COMPANY
Kaspa Pharmaceutical [Thailand]
Co., Ltd.
Business Type :
Importer and distributor
of pharmaceutical products.
LITIGATION
Bankruptcy and
Receivership
There are no
litigation on bankruptcy
and receivership cases
filed against the
subject found at
Legal Execution Department
for the past
five years.
Others
There are no
legal suits filed
against the subject
for the past
two years.
CREDIT
Sales are by
cash or on
the credits term
of 30-60 days.
Local bills are
paid by cash
or on the
credits term of
30-60 days.
Imports are by
T/T.
BANKING
The
banker’s name was
not disclosed.
EMPLOYMENT
The
subject employs 8
staff.
LOCATION
DETAILS
The
premise is rented
for administrative office
at the heading
address. Premise is
located in commercial/residential area.
COMMENT
The
subject is newly established company
engaged in importing and distributing of pharmaceuticals for
domestic consumption. Subject is
in early stage operation therefore any
business engagement should be
on secured basis only.
The
capital was registered
at Bht. 3,000,000 divided into 600,000 shares of Bht.
5 each with
fully paid.
THE
SHAREHOLDERS LISTED WERE
: [as at
December 24, 2011]
|
NAME |
HOLDING |
% |
|
|
|
|
|
Mr. Nirav Vikram Maniar Nationality: Indian Address : Mumbai,
India |
234,000 |
39.00 |
|
Mr. Saridphong Mekworawuth Nationality: Thai Address : 549/360
Soi Jaransanitwong 37,
Jaransanitwong Rd.,
Bangkhunsri, Bangkoknoi,
Bangkok |
210,000 |
35.00 |
|
Mr. Prawit Plaimas Nationality: Thai Address : 14/2858
Moo 1, Bangbuathong, Nonthaburi |
96,000 |
16.00 |
|
Mr. Suched Rastoji Nationality: Indian Address : Mumbai,
India |
60,000 |
10.00 |
Total Shareholders : 4
Share Structure [as
at December 24,
2011]
|
Nationality |
Shareholders |
No. of Share |
% Shares |
|
|
|
|
|
|
Thai |
2 |
306,000 |
51.00 |
|
Foreign - Indian |
2 |
294,000 |
49.00 |
|
Total |
4 |
600,000 |
100.00 |
NAME OF AUDITOR
& CERTIFIED PUBLIC
ACCOUNTANT NO. :
None
Note
Due to the
subject has been established in
2012, therefore financial
information has not
yet available.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.68 |
|
UK Pound |
1 |
Rs.86.52 |
|
Euro |
1 |
Rs.69.86 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.